• SENSEX 76,617.44
    592.93 (+0.78%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • IndusInd Bank
    708.45 1,576.00(%)
  • Kalyan Jewellers
    519.15 794.60(%)
  • Dr Lal Pathlabs
    2,508.00 3,645.00(%)
  • ICICI BLR Growth
    1,003.14 1,001.47(%)
  • Vodafone Idea
    8.33 19.15(%)
  • Bharat Electron
    274.50 204.00(%)
  • Quadrant Future
    605.00 743.45(%)
  • Zomato Ltd
    212.60 304.50(%)
  • SRF
    2,986.25 3,074.95(%)
  • Bengal & Assam
    7,450.00 11,498.90(%)
  • ICICI Bank
    1,338.00 1,372.50(%)
  • Mazagon Dock
    2,610.00 2,929.98(%)
  • Suzlon Energy
    57.74 86.04(%)
  • SpiceJet
    46.10 79.90(%)
  • Dixon Technolog.
    13,485.00 19,149.80(%)
  • Adani Green
    944.95 2,173.65(%)
  • Aegis Logistics
    830.35 1,035.70(%)
  • Hind.Aeronautics
    4,252.00 5,675.00(%)
  • M & M
    2,660.50 3,276.30(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Dishman Carbogen Amcis Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 67697.0
  • ISIN : INE385W01011
220.45 3 (1.22%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    213.91

  • Today’s High

    223.44

  • Open

    215.00

  • Perv Close

    217.79

  • 52W Low

    133.00

  • 52W High

    307.98

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    3,456.28

  • Div & Yield %

    0.00

  • Book Value(₹)

    258.02

  • Debt-Equity Ratio

    1.22

  • AGM Date

    01-Apr-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.40

  • Mar.Cap (₹Cr.)

    3,456.28

  • RONW (%)

    -2.68

  • ROCE (%)

    -0.03

Score Board

  • Equity (₹ in Cr.)

    31.36

  • BV (₹)

    258.00

  • Sales( ₹ in Cr.)

    327.35

  • NP (in Cr.)

    -75.33

  • NP Var(%)

    -34.0

  • Div%

    0.0

  • CPS (₹)

    1.70

  • EPS (₹)

    -4.80

  • Traded Value (₹ in Lakhs)

    3,465.69

  • 52 Week High

    307.98

  • 52 Week Low

    133.00

  • Price BSE

    221.0

  • Price NSE

    220.00

  • Market Capital( in Cr.)

    3,465.69

  • P/C Ratio

    131.80

  • P/E Ratio

    -46.00

  • Price Vs.BV

    -4.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 327.35 402.55 306.61 200.32 580.74 549.47
Excise Duty 287.73 369.54 207.99 155.37 509.20 435.90
Net Sales 327.35 402.55 306.61 200.32 580.74 549.47
Other Income 63.05 52.16 60.39 66.15 69.55 71.68
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 390.40 454.71 367.00 266.47 650.29 621.15
EXPENDITURE :
Raw Materials 287.73 369.54 207.99 155.37 509.20 435.90
Power & Fuel Cost 287.73 369.54 207.99 155.37 509.20 435.90
Employee Cost 91.54 86.13 79.04 58.23 88.87 80.27
Other Manufacturing Expenses 13.93 20.49 -4.78 36.53 13.51 4.03
Selling & Administrative Expenses 43.12 53.18 46.59 29.47 43.36 49.28
Miscellaneous Expenses 13.93 20.49 -4.78 36.53 13.51 4.03
Less : Pre-operative Expenses Capitalised :
Total Expenditure 490.35 548.91 444.40 428.49 594.83 539.42
Operating Profit 55.99 63.64 46.84 31.16 61.31 59.52
Interest 68.19 57.92 37.23 34.17 47.02 47.43
Gross Profit -103.00 -96.20 -83.31 -162.02 55.46 81.73
Depreciation 101.61 96.20 140.07 141.35 140.65 136.31
Profit Before Tax -103.00 -96.20 -83.31 -162.02 55.46 81.73
Tax 0.00 0.00 0.00 0.00 9.30 17.01
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -37.65 -37.33 -22.16 46.15 7.64 8.71
Reported Net Profit -76.41 -58.87 -30.47 -226.14 38.52 56.01
Extraordinary Items -103.00 -96.20 -83.31 -162.02 55.46 81.73
Adjusted Net Profit -76.41 -58.87 -30.47 -226.14 38.52 56.01
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 -1.08 -6.67 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 3.23
P & L Balance carried down -76.41 -58.87 -30.47 -226.14 38.52 56.01
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 10.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.20
Earnings Per Share-Unit Curr -4.87 -3.75 -2.01 -14.85 2.46 3.47
Book Value 0.00 0.00 0.00 0.00 0.00 3.23
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 3.23

Shareholding Pattern

  • Promoter Group

    59.32%

  • Public Share Holding

    40.68%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,000 0.00 5,000 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 93,007,442 59.32 93,007,442 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 13,710,693 8.75 13,710,693 59
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,915,763 1.22 1,915,763 6
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 312,500 0.20 312,500 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 15,938,956 10.17 15,938,956 68
2] Non Institution
Bodies Corporate 2,604,977 1.66 2,604,977 315
Clearing Members 522 0.00 522 5
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,428,912 0.91 1,428,912 976
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,380,716 0.88 1,380,716 1,323
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 16,684,948 10.64 16,684,948 26
Individuals holding nominal share capital up to Rs. 1 lakh 24,429,788 15.58 24,429,093 50,063
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,190 0.00 1,190 2
Others 36,786 0.02 36,786 2
Sub Total 47,836,697 30.51 47,836,002 52,748
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 156,783,095 100.00 156,782,400 52,822

Company Background

Dishman Carbogen Amcis LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Dishman Carbogen Amcis Ltd
  • BSE Code : 67697.0
  • ISIN : INE385W01011

  • Incorporation Year

    2007

  • Registered Office

    Dishman Corporate House
    Iscon-Bopal Road Ambli, Ahmedabad,
    Gujarat-380058

  • Telephone

    91-2717-400102/124

  • FAX

  • Chairman

    Janmejay R Vyas

  • Managing Director

    Arpit J Vyas

  • Company Secretary

    Shrima Dave

  • Auditor

    T R Chadha & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Dishman Carbogen Amcis Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Dishman Carbogen 221.05 390.40 327.35 -103.29 0.00
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92